June 2, 2020, Vol 323, No. 21, Pages 2111-2210
Preserving Clinical Trial Integrity During the Coronavirus Pandemic
Mary M. McDermott, MD; Anne B. Newman, MD, MPH
free access has active quiz
JAMA. 2020;323(21):2135-2136. doi:10.1001/jama.2020.4689
This Viewpoint discusses ways the coronavirus pandemic is threatening clinical trial conduct and enrollment, and suggests ways to adapt, including changes to how outcomes data are collected and how interventions are delivered and monitored, to minimize trial disruption, maximize trial benefit, and ensure patient health and safety during the pandemic.